Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
5.85
-0.12 (-2.01%)
At close: Jun 27, 2025, 4:00 PM
5.89
+0.04 (0.68%)
After-hours: Jun 27, 2025, 4:04 PM EDT
Tenax Therapeutics Market Cap
Tenax Therapeutics has a market cap or net worth of $232.20 million as of June 27, 2025. Its market cap has increased by 3,365.71% in one year.
Market Cap
232.20M
Enterprise Value
120.76M
1-Year Change
3,365.71%
Ranking
Category
Stock Price
$5.85
Market Cap Chart
Since October 31, 2001, Tenax Therapeutics's market cap has increased from $13.80M to $232.20M, an increase of 1,582.63%. That is a compound annual growth rate of 12.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 24.30M | 15.17% |
| Dec 31, 2024 | 21.10M | 219.70% |
| Dec 29, 2023 | 6.60M | 32.00% |
| Dec 30, 2022 | 5.00M | -80.92% |
| Dec 31, 2021 | 26.20M | 11.49% |
| Dec 31, 2020 | 23.50M | 147.37% |
| Dec 31, 2019 | 9.50M | 427.78% |
| Dec 31, 2018 | 1.80M | -86.96% |
| Dec 29, 2017 | 13.80M | -74.82% |
| Dec 30, 2016 | 54.80M | -40.63% |
| Dec 31, 2015 | 92.30M | -14.54% |
| Dec 31, 2014 | 108.00M | 125.94% |
| Dec 31, 2013 | 47.80M | 123.36% |
| Dec 31, 2012 | 21.40M | -45.69% |
| Dec 30, 2011 | 39.40M | -13.41% |
| Dec 31, 2010 | 45.50M | -62.86% |
| Dec 31, 2009 | 122.50M | 213.30% |
| Dec 31, 2008 | 39.10M | -10.93% |
| Dec 31, 2007 | 43.90M | 92.54% |
| Dec 29, 2006 | 22.80M | 25.97% |
| Dec 30, 2005 | 18.10M | -40.66% |
| Dec 31, 2004 | 30.50M | -57.04% |
| Dec 31, 2003 | 71.00M | 332.93% |
| Dec 31, 2002 | 16.40M | 18.84% |
| Dec 31, 2001 | 13.80M | - |
View and export this data all the way back to 2001.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 217.42B |